Drug intelligence / Profile preview

recombinant canine thyroid-stimulating hormone analog

Development stage
Preclinical
Lead developer
Trophogen
Modality
Recombinant Proteins and Enzymes
Administration
Intravenous
01

Overview

Recombinant canine thyroid-stimulating hormone (TSH) analog is a recombinant protein developed by Trophogen for veterinary applications, specifically for use in dogs. It is designed to act as an agonist of the thyroid-stimulating hormone receptor (TSHR), mimicking the physiological role of endogenous TSH in stimulating the thyroid gland to produce and release thyroid hormones. This analog is intended for diagnostic purposes, such as the TSH stimulation test used to identify hypothyroidism, and potentially for therapeutic applications. By utilizing recombinant technology, the product aims to provide a consistent and potent alternative to pituitary-derived TSH for veterinary diagnostic testing. The drug is currently in the preclinical stage of development.

Other names
canine TSH analogrTSH (canine)recombinant canine TSH analog
02

Targets

TSHR (Thyroid-stimulating hormone receptor)

Beyond the preview

Go deeper on recombinant canine thyroid-stimulating hormone analog.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on recombinant canine thyroid-stimulating hormone analog.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call